Strategies for prevention of anthracycline cardiotoxicity
- 31 January 1993
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 19 (1), 57-77
- https://doi.org/10.1016/0305-7372(93)90027-o
Abstract
No abstract availableThis publication has 73 references indexed in Scilit:
- Usefulness of a free radical scavenger in preventing doxorubicin-induced heart failure in dogsThe American Journal of Cardiology, 1985
- Enhancement of reactive oxygen-dependent mitochondrial membrane lipid peroxidation by the anticancer drug adriamycinBiochemical Pharmacology, 1985
- Biological Properties of ICRF-159 and Related Bis(dioxopiperazine) CompoundsPublished by Elsevier ,1982
- Mechanism of adriamycin cardiotoxicity: Evidence for oxidative stressLife Sciences, 1981
- The Anthracycline Antineoplastic DrugsNew England Journal of Medicine, 1981
- Early anthracycline cardiotoxicityThe American Journal of Medicine, 1978
- Adriamycin stimulated superoxide formation in submitochondrial particlesChemico-Biological Interactions, 1977
- Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycinBiochemical and Biophysical Research Communications, 1977
- Cardiotoxicity of adriamycin and related anthracyclinesCancer Treatment Reviews, 1976
- Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease.Clinical evaluation with special reference to childhood leukemiaCancer, 1967